Dr. M Reza Movahed received his med degree and Dr. Med (Ph.) from Medizinische Hochschule Hannover, Germany. His Interventional Cardiology at Yale University Hospital, New Haven, CT in 2000. In July 2010, Dr. Movahed was promoted to Prof. of Med, Tenure at the University of Arizona College Of Medicine in Tucson with over 250 peer-reviewed publications. He is also appointed to Clinical Prof. of Med at the U of A, Phoenix in 2018. He has been Director of Cardiac Cath Lab and Nuclear Cardiology at the UCI Director of CCU and Medical Director of Cardiac Transplantation at the U of. A In 2007. In May 2012, he was The Regional Cardiology Director of CareMore in Arizona until 2020. He is world-renowned for his coronary bifurcation classification known as “The Movahed Classification” He is also known for discovery of the flattening of interventricular septum as a sign of right ventricular overload the so-called “ Movahed’s sign seen on Gated SPECT and reverse “Movahed Maneuver” that can be used for improvement of stent deliverability during difficult and tortuous vein graft interventions. He has two cardiovascular patents. One is a device for the removal of contrast from a coronary sinus during coronary angiography or intervention in order to reduce contrast exposure to kidneys for the prevention of contrast-induced nephropathy. The other one is a method and device that can measure the cross-sectional lumen of a vessel using impedance sensors. He is AHA board president in Arizona.